重组大鼠再生增强因子救治急性肝衰竭的实验研究

肝再生增强因子是一种新的肝细胞增殖刺激因子。在本实验利用我们自行表达的重组大鼠肝再生增强因子,观察了其对四氯化碳诱导的急性肝功能衰竭大鼠的救治作用。初步结果表明：重组肝再生增强因子能够显著提高中毒大鼠的存活率,降低中毒大鼠外周血ＡＬＴ,ＡＳＴ的水平。提示重组肝再生增强因子可能应用临床治疗严重肝病。     

人肝再生增强因子在大肠杆菌中的高效表达及生物学活性研究

将人肝再生增强因子编码区ｃＤＮＡ亚克隆于表达质粒ｐＢＶ－２２０,构建了高效表达菌株,其特异表达蛋白占细菌可溶性蛋白的２０％,表达产物在体内具有促进肝细胞ＤＮＡ合成和提高ＣＣｌ４致中毒性肝功能衰竭大鼠存活率的作用。     

人肝再生增强因子在大肠杆菌中的高效表达及生物学活…

将人肝再生增强因子编码区ｃＤＮＡ亚克隆于表达质业ＰＢＶ－２２０,构建了高效表达菌株,其特异表达蛋白占细菌可溶性蛋白的２０％,表达产物在体内具有促进肝细胞ＤＮＡ合成和提高ＣＣｌ４致中毒性肝功能衰竭大鼠存活率的作用。     

大鼠再生肝刺激因子抗四氯化碳损伤的研究

我们以往的研究证明,大鼠再生肝具有抗四氯化碳损伤的能力。本工作进一步研究其机制,首先从部分（６８％）肝切除后不同的再生肝的取肝刺激因子,用＾３Ｈ胸腺嘧喧核苷测定ｒＨＳＳ的生物活性,结果表明部分切除肝后７２ｈ的ｒＨＳＳ活性较对照组约增加７．７倍。然后将ｒＨＳＳ注射给小鼠,观察其抗ＣＣｌ４损伤肝的效应,具体表现如下：ｒＨＳＳ能减少ＣＣｌ４中毒小鼠的死亡率和降低ＣＣｌ４所增高的血清谷丙转氨酶和谷草转氨酶     

肝再生增强因子

肝脏是机体具有强大再生能力的脏器 ,目前已知的肝再生相关因子如肝细胞生长因子 (ＨＧＦ)、转化生长因子 α(ＴＧＦ α)、表皮生长因子 (ＥＧＦ)等 ,均难以解释具有器官特异性的肝再生调控机制 ,因此寻找新型肝再生调控因子一直是该领域的热点[1] 。1994年 8月 ,Ｈａｇｉｙａ等[2 ] 从初断乳大鼠肝组织中克隆到一种新型的促肝细胞增殖因子 ,称为肝再生增强因子 (ａｕｇｍｅｎｔｅｒｏｆｌｉｖｅｒｒｅｇｅｎｅｒａｔｉｏｎ ,ＡＬＲ)。近来研究发现 ,ＡＬＲ是一种特殊的促肝细胞分裂原 ,在肝损伤修复过程中发挥重要作用。1.ＡＬＲ基因大鼠…     

小鼠肝部分切除模型

小鼠肝部分切除模型是在经典的大鼠模型基础上发展起来的。随着显微外科技术的发展和小鼠腹部手术围手术期管理的完善,快速、可靠、重复性高的小鼠模型得以建立。因为成本较低,且存在大量为研究肝切除后肝再生的转基因小鼠,小鼠已经成为研究肝再生的重要动物模型。肝再生的调控相当复杂,且不是由单一因素控制的,因此需要多种类的转基因小鼠进行肝切除后肝再生研究来明确各因子在肝再生过程中的确切作用与机制。通过小鼠肝切除后肝再生的研究,目前已证实的参与调控肝再生的细胞因子和生长因子有:肝再生增强因子(ALR)、肿瘤坏死因子α(TNFα)、白介素6(IL-6)、白介素1(IL-1)、肝细胞生长因子(HGF)、去甲肾上腺素(NE)、卵泡抑素(FS)、转化生长因子α(TGF-α)、转化生长因子β-1(TGF-β-1)等。     

肝大部切除后肝再生调节的研究

肝再生调节因子主要有促使肝细胞增殖的刺激因子和抑制因子两大类。前者如ＥＧＦ、ＩＧＦ－α、ＨＳＳ、ＨＰＴＢ、ＨＰＴＡ／ＨＧＦ等,它们是肝细胞增殖的完全促分裂原;后者主要有肝抑素、ＴＧＦ－β等,它们对肝细胞增殖具有负性调节作用。本实验室已提取纯化了大鼠肝抑素并证明了它的生物效应。肝大部切除后的动物在上述两类因子的调控下,肝细胞增殖迅速而有规律,肝再生完成后肝细胞增殖趋于停止。     

重组人肝再生增强因子在体外能刺激HTC肝癌细胞DNA合成

在成功克隆人肝再生增强因子（ｈＡＬＲ）ｃＤＮＡ的基础上,本研究将人ＡＬＲ编码区ｃＤＮＡ亚克隆于真核瞬间表达质粒ｐＣＤＮＡ Ｉ,构建了真核表达质粒ｐＣＤＮＡ Ｉ－ｈＡＬＲ,转染ｃｏｓ－７细胞后,表达产物生物活性检测表明：真核表达的ｈＡＬＲ在体外能刺激ＨＴＣ肝癌细胞增殖,这一体外活性的确定为重组人ＡＬＲ的纯化提供了简洁、可靠的检测方法。     

人肝刺激因子对大鼠实验性慢性肝损伤的保护作用

从健康孕妇水囊引产４─６个月龄的胎儿取肝,采用ＬａＢｒｅｃｑｕｅ方法提取人肝刺激因子（ｈＨＳＳ）。经３Ｈ－胸腺嘧啶核苷参入肝ＤＮＡ法测定其生物活性。表明此ｈＨＳＳ可刺激肝细胞ＤＮＡ合成。采用皮下注射ＣＣｌ４和饮用１０％乙醇来制备慢性肝损伤动物模型,观察了ｈＨＳＳ的保护肝脏作用。结果表明：ｈＨＳＳ可使ＣＣｌ４－乙醇所致慢性肝损伤大鼠的死亡率、血清谷丙转氨酶水平、肝组织中羟脯氨酸含量的升高以及肝组织中丙二醛的含量降低。肝组织切片表明：ｈＨＳＳ能减轻肝组织的损伤程度,促进肝细胞再生,并能明显防止肝纤维化的形成和发展。可见,ｈＨＳＳ对ＣＣｌ４－乙醇所致的慢性肝损伤大鼠有明显的保护作用,其机制可能与促进肝细胞再生及抑制肝细胞膜的脂质过氧化有关。     

肝再生增强因子的cDNA克隆,表达及表达产物的生物活性研究

以肝部分切除后再生肝组织为起始材料,利用ＲＴ－ＰＣＲ扩增出大夺再生增强因子（ＡＬＲ）,亚克隆子于ＰＧＥＭ－Ｔ载体,核苷酸序列测定证实为大鼠ＡＬＲ;将ＡＬＰＣＤＮＡ亚克隆于ＰＢＶ２２０质粒,构建了原核表达载体,并获高效表达菌株,特异表达蛋白占细菌总蛋白的１５％,原核表达的ＡＬＲ在体外缺乏促进大鼠原代培养肝细胞及ＳＭＭＣ－７７２１肝癌细胞ＤＮＡ合成的活性,但天体内１／３肝部分切除模型中可刺激肝细胞ＤＮ     

肝部分切除后肝再生增强因子信使核糖核酸（mRNA）表达增强

肝再生增强因子（ＡＬＲ）是一种新的肝增殖刺激因子。本研究选择７０％肝部分切除（ＰＨ）大鼠为模型,观察了ＰＨ后残存肝组织胞浆液促肝细胞增殖活性与ＡＬＲ特异ｍＲＮＡ表达动态变化的关系。发现正常肝组织几无ＡＬＲ ｍＲＮＡ表达,其肝胞质液也无促肝细胞增殖活性;７０％ＰＨ后１２ｈ肝组织ＡＬＲ ｍＲＮＡ表达明显增加,并于术后２４ｈ达高峰,肝胞质液活性也于术后２４ｈ内达高峰,这种ｍＲＮＡ表达－效应的时间关系提示     

Regulation of polyamine synthesis in human hepatocytes by hepatotrophic factor augmenter of liver regeneration

Different stages of liver regeneration are regulated by a variety of factors such as the liver growth associated protein ALR, augmenter of liver regeneration. Furthermore, small molecules like polyamines were proven to be essential for hepatic growth and regeneration. Therefore, using primary human hepatocytes in vitro we investigated the effect of ALR on the biosynthesis of polyamines. We demonstrated by HPLC analysis that recombinant ALR enhanced intracellular hepatic putrescine, spermidine, and spermine levels within 9-12h. The activation of polyamine biosynthesis was dose dependent with putrescine showing the strongest increase. Additionally, ALR treatment induced mRNA expression of ornithine decarboxylase (ODC) and S-adenosylmethionine decarboxylase, both key enzymes of polyamine biosynthesis. Further, ALR induced c-myc mRNA expression, a regulator of ODC expression, and therefore we assume that ALR exerts its liver regeneration augmenting effects through stimulation of its signalling pathway leading in part to enhanced polyamine synthesis.     

重组[B18Ile]人胰岛素的鉴定和特征

突变体「Ｂ１８Ｉｌｅ」猪胰岛素前体经分离纯化,转肽,得到重组「Ｂ１８Ｉｌｅ」人胰素「Ｂ１８Ｉｌｅ」人胰岛素能结晶,其与受体的结合能力为猪胰岛素的８２％,保留了与猪胰岛素基本相同的体内活力,从本文结果和分析表明Ｂ１８Ｖａｌ可能不是胰岛素表现生物功能所必需的。     

Augmenter of liver regeneration: Essential for growth and beyond

Liver regeneration is a well-orchestrated process that is triggered by tissue loss due to trauma or surgical resection and by hepatocellular death induced by toxins or viral infections. Due to the central role of the liver for body homeostasis, intensive research was conducted to identify factors that might contribute to hepatic growth and regeneration. Using a model of partial hepatectomy several factors including cytokines and growth factors that regulate this process were discovered. Among them, a protein was identified to specifically support liver regeneration and therefore was named ALR (Augmenter of Liver Regeneration). ALR protein is encoded by GFER (growth factor erv1-like) gene and can be regulated by various stimuli. ALR is expressed in different tissues in three isoforms which are associated with multiple functions: The long forms of ALR were found in the inner-mitochondrial space (IMS) and the cytosol. Mitochondrial ALR (23 kDa) was shown to cooperate with Mia40 to insure adequate protein folding during import into IMS. On the other hand short form ALR, located mainly in the cytosol, was attributed with anti-apoptotic and anti-oxidative properties as well as its inflammation and metabolism modulating effects. Although a considerable amount of work has been devoted to summarizing the knowledge on ALR, an investigation of ALR expression in different organs (location, subcellular localization) as well as delineation between the isoforms and function of ALR is still missing. This review provides a comprehensive evaluation of ALR structure and expression of different ALR isoforms. Furthermore, we highlight the functional role of endogenously expressed and exogenously applied ALR, as well as an analysis of the clinical importance of ALR, with emphasis on liver disease and in vivo models, as well as the consequences of mutations in the GFER gene.     

Human augmenter of liver regeneration: molecular cloning, biological activity and roles in liver regeneration

The complete amino acid sequence of human augmenter of liver regeneration (hALR) was reported by deduction from nucleotide sequence of its complementary DNA . The cDNA for hALR was isolated by screening a human fetal liver cDNA library and the sequencing of this insert revealed an open reading frame encoding a protein with 125aa and highly homologous (87% ) with rat ALR encoding sequence. The recombinant hALR expressed from its cDNA in transient expression experiments in cos-7 cells could stimulate DNA synthesis of HTC hepatoma cell in the dose-dependent and heat-resistant way. Northern blot analysis with rat ALR cDNA as probe confirmed that ALR mRNA was expressed in the normal rat liver at low level and that dramatically increased in the regenerating liver after partial hepatectomied rat. This size of hALR mRNA is 1.4 kb long and expressed in human fetal liver, kidney and testis. These findings indicated that liver itself may be the resource of ALR and suggested that ALR seems to be an im-portant parac     

Nrf2 Activates Augmenter of Liver Regeneration (ALR) via Antioxidant Response Element and Links Oxidative Stress to Liver Regeneration

Liver regeneration can be impaired by permanent oxidative stress and activation of nuclear factor erythroid 2–related factor 2 (Nrf2), known to regulate the cellular antioxidant response, and has been shown to improve the process of liver regeneration. A variety of factors regulate hepatic tissue regeneration, among them augmenter of liver regeneration (ALR), attained great attention as being survival factors for the liver with proproliferative and antiapoptotic properties. Here we determined the Nrf2/antioxidant response element (ARE) regulated expression of ALR and show ALR as a target gene of Nrf2 in vitro and in vivo. The ALR promoter comprises an ARE binding site and, therefore, ALR expression can be induced by ARE-activator tertiary butylhydroquinone (tBHQ) in hepatoma cells and primary human hepatocytes (PHH). Promoter activity and expression of ALR were enhanced after cotransfection of Nrf2 compared with control and dominant negative mutant of Nrf2. Performing partial hepatectomy in livers from Nrf2^+/+ mice compared with Nrf2^−/− knock-out (KO) mice, we found increased expression of ALR in addition to known antioxidant ARE-regulated genes. Furthermore, we observed increased ALR expression in hepatitis B virus (HBV) compared with hepatitis C virus (HCV) positive hepatoma cells and PHH. Recently, it was demonstrated that HBV infection activates Nrf2 and, now, we add results showing increased ALR expression in liver samples from patients infected with HBV. ALR is regulated by Nrf2, acts as a liver regeneration and antioxidative protein and, therefore, links oxidative stress to hepatic regeneration to ensure survival of damaged cells.     

Augmenter of liver regeneration (ALR) gene therapy attenuates CCl4-induced liver injury and fibrosis in rats

Liver fibrosis represents a process of healing and scarring in response to chronic liver injury. Augmenter of liver regeneration (ALR) has been shown to protect hepatocytes from various toxins. The aim of this study was to investigate the effects of ALR gene therapy on liver injury and fibrosis induced by CCl₄ in rats and further explore the underlying mechanisms. Human ALR expression plasmid was delivered via the tail vein. ALR gene therapy might protect the liver from CCl₄-induced injury and fibrogenesis by attenuating the mitochondrial dysfunction, suppressing oxidative stress, and inhibiting activation of HSCs. This report demonstrated that ALR gene therapy protected against the ATP loss, increased the activity of ATPase, decreased intrahepatic reactive oxygen species level, and down-regulated transforming growth factor-β1, platelet-derived growth factor-BB, and α-smooth muscle actin expression. Following gene transfer liver function tests were significantly improved. In brief, ALR gene therapy might be an effective therapeutic reagent for liver fibrosis with potential clinical applications.